Correlation of CEA levels with metabolic tumor volume, assessed by FDG PET and RECIST complient size measurement in patients with recurrent and/or metastatic colorectal cancer

被引：0
|
作者：
Bochev, P. [1 ]
Bocheva, Y. [2 ]
Mateva, G. [1 ]
机构：
[1] Acibadem Cityclin UMBAL Mladost Oncol Hosp, Sofia, Bulgaria
[2] Med Univ Prof Dr Paraskev Stoyanov, Varna, Bulgaria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EPS-031
引用
收藏
页码：S70 / S70
页数：1
相关论文
共 50 条
  • [41] Prognostic Value of Metabolic Tumor Volume Measured by F-18-FDG PET/ CT in Esophageal Cancer Patients
    Soydal, Cigdem
    Yuksel, Cabir
    Kucuk, Ozlem N.
    Okten, Ilker
    Ozkan, Elgin
    Erdogan, Beyza Doganay
    MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, 2014, 23 (01) : 12 - 15
  • [42] Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab
    Awada, G.
    Ozdemir, I.
    Schwarze, J. K.
    Daeninck, E.
    Gondry, O.
    Jansen, Y.
    Seremet, T.
    Keyaerts, M.
    Everaert, H.
    Neyns, B.
    ANNALS OF ONCOLOGY, 2018, 29
  • [43] Predicting survival in metastatic triple negative breast cancer patients with FDG PET/CT-based tumor volume quantification
    Marinelli, Brett
    Espinet, Carina
    Ulaner, Gary
    Jochelson, Maxine
    Weber, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [44] Predicting survival in metastatic triple negative breast cancer patients with FDG PET/CT-based tumor volume quantification
    Marinelli, Brett
    Espinet, Carina
    Ulaner, Gary
    Jochelson, Maxine
    Weber, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [45] Prognostic value of FDG PET/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients
    Marinelli, Brett
    Espinet-Col, Carina
    Ulaner, Gary A.
    McArthur, Heather L.
    Gonen, Mithat
    Jochelson, Maxine
    Weber, Wolfgang A.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 6 (02): : 120 - 127
  • [46] Can pretreatment metabolic tumor volume measured by F-18 FDG PET/CT predict recurrence or treatment response in stage IV colorectal cancer patients?
    Kang, Sung Min
    Song, Bong-Il
    Lee, Hong-Je
    Seo, Ji-Hyoung
    Lee, Sang-Woo
    Yoo, Jeongsoo
    Ahn, Byeong-Cheol
    Lee, Jaetae
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [47] F-18 FDG PET/CT metabolic tumor volume predicts outcome in patients with disseminated epithelial ovarian cancer
    Gallicchio, R.
    Capacchione, D.
    Giacomobono, S.
    Nardelli, A.
    Bozza, G.
    Sirignano, C.
    Troiani, L.
    Improta, G.
    Tempone, A.
    Nappi, A.
    Storto, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S269 - S269
  • [48] Heterogeneity of Metabolic Parameters and Impact on Early Response Evaluation with FDG PET/CT in Patients with Metastatic Colorectal Cancer treated with Cetuximab Monotherapy
    van Helden, E. J.
    Hoekstra, O. S.
    Boellaard, R.
    Verheul, H. M. W.
    van Oordt, C. W. Menke-van der Houven
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S713 - S714
  • [49] Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma
    Fonti, R.
    Larobina, M.
    De Luca, S.
    Fabbricini, R.
    Catalano, L.
    Pace, L.
    Del Vecchio, S.
    Salvatore, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S216 - S216
  • [50] Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas
    Patel, Dhaval
    Mehta, Amit
    Nilubol, Naris
    Dieckmann, William
    Pacak, Karel
    Kebebew, Electron
    ANNALS OF SURGERY, 2016, 263 (03) : 582 - 587
12345